SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Best Agrolife shines as its arm gets licence for indigenous manufacturing of Spiromesifen Technical

17 Feb 2022 Evaluate

Best Agrolife is currently trading at Rs. 1016.35, up by 63.95 points or 6.71% from its previous closing of Rs. 952.40 on the BSE.

The scrip opened at Rs. 952.95 and has touched a high and low of Rs. 1048.25 and Rs. 952.95 respectively. So far 4273 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1399.70 on 04-Nov-2021 and a 52 week low of Rs. 203.00 on 19-May-2021.

Last one week high and low of the scrip stood at Rs. 1048.25 and Rs. 880.25 respectively. The current market cap of the company is Rs. 2411.76 crore.

The promoters holding in the company stood at 45.42%, while Institutions and Non-Institutions held 11.41% and 43.17% respectively.

Best Agrolife’s wholly owned subsidiary -- Best Crop Science has been granted licence for indigenous manufacturing of Spiromesifen Technical by Central Insecticides Board & Registration Committee.

The Spiromesifen acts as a very effective insecticide and miticide that controls red spider mite in brinjal, whitefly & mite in cotton, European red mite & red spider mite in apple, chili & 0kra, yellow mite in chili etc.

Best Agrolife engaged in business of trading of all kinds of plastic & chemicals raw material and products.

Best Agrolife Share Price

19.19 -0.26 (-1.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×